The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model

AIDS. 2006 Mar 21;20(5):751-62. doi: 10.1097/01.aids.0000216376.07185.cc.

Abstract

Objective: To explore the potential impact of enhanced tuberculosis (TB) diagnostic techniques as a TB control strategy in an adult population with high HIV prevalence.

Design: A compartmental difference-equation model of TB/HIV was developed using parameter estimates from the literature.

Methods: The impact of five TB control interventions (rapid molecular testing, mycobacterial culture, community-wide and HIV-targeted active case finding, and highly active antiretroviral therapy) on TB incidence, prevalence, and mortality was modeled in a steady-state population with an HIV prevalence of 17% and annual TB incidence of 409 per 100 000. Sensitivity analyses assessed the influence of each model parameter on the interventions' mortality impact.

Results: Enhanced diagnostic techniques (rapid molecular testing or culture) are each projected to reduce TB prevalence and mortality by 20% or more, an impact similar to that of active case-finding in 33% of the general community and greater than the effect achievable by case-finding or antiretroviral treatment efforts in HIV-positive patients alone. The projected impact of enhanced diagnostics on TB incidence (< 10% reduction) is smaller. The impact of TB diagnostics is sensitive to the quality of existing diagnostic standards and the level of access to diagnostic services, but is robust across a wide range of population parameters including HIV and TB incidence.

Conclusions: Enhanced TB diagnostic techniques may have substantial impact on TB morbidity and mortality in HIV-endemic regions. As TB rates continue to increase in these areas, enhanced diagnostic techniques merit further consideration as TB control strategies.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS-Related Opportunistic Infections / diagnosis*
  • Adolescent
  • Adult
  • Anti-HIV Agents / therapeutic use
  • Antiretroviral Therapy, Highly Active
  • Bacterial Typing Techniques
  • Communicable Disease Control
  • DNA, Bacterial / analysis
  • Developing Countries*
  • Disease Outbreaks
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • Health Services Accessibility
  • Humans
  • Incidence
  • Middle Aged
  • Models, Statistical*
  • Mycobacterium tuberculosis* / genetics
  • Mycobacterium tuberculosis* / isolation & purification
  • Prevalence
  • Tuberculosis / diagnosis*
  • Tuberculosis / epidemiology
  • Tuberculosis / virology

Substances

  • Anti-HIV Agents
  • DNA, Bacterial